CDSCO Licence for Nebulizers in India: Class B Registration, ISO 27427 and Process

A nebulizer turns liquid medication into a fine mist a patient inhales, delivering drugs deep into the airways for asthma, COPD and other respiratory conditions. Because it is an active device that delivers medication to the lungs, CDSCO regulates the nebulizer as a Class B device with the nebulizing-system performance standard and electro-medical safety behind the licence. This guide covers the full CDSCO pathway for nebulizers under the Medical Devices Rules, 2017 — classification, licence route, ISO 27427, the documents, the fees and the timeline. This guide explains CDSCO registration for nebulizers in India — risk class, licence forms, standards, documents, fees and timeline.

Is a CDSCO Registration Mandatory for Nebulizers?

Yes. A nebulizer is a notified Class B medical device and cannot be manufactured, imported or sold in India without a CDSCO licence. A domestic manufacturer holds a Form MD-5 licence from the State Licensing Authority. An importer holds a Form MD-15 import licence through an Indian Authorised Agent. Compressor (jet), ultrasonic and vibrating-mesh nebulizers all fall within the framework.

Risk Classification of Nebulizers

Every medical device in India falls into one of four risk classes (A, B, C, D) under the First Schedule of the Medical Devices Rules, 2017. The class fixes the authority, the form, the fee, the audit route and the timeline.

Nebulizers are classified as Class B (low-to-moderate risk). A nebulizer is an active device that delivers medication to the respiratory tract, whose output affects dosing, placing it in Class B under the First Schedule. Where a device could fall in two classes the higher class applies, and an accessory is classified in its own right. Always confirm against the current CDSCO classification list.

Which CDSCO Licence You Need for Nebulizers

  • To manufacture nebulizers in India (Class B) — apply in Form MD-3 to the State Licensing Authority (SLA). The licensing authority grants the licence in Form MD-5. A CDSCO-empanelled Notified Body audits the site. For Class A the audit is post-grant. For Class B the Notified Body conducts it before the licensing authority grants the licence.
  • To import nebulizers (any class) — the overseas manufacturer appoints an Indian Authorised Agent who files Form MD-14 with the Central Licensing Authority; CDSCO grants the import licence in Form MD-15.
  • Test licence — for a small quantity imported or made for testing, evaluation, demonstration or clinical investigation: Form MD-12 application, Form MD-13 licence.
  • Loan licence — using another licensee’s approved premises: Form MD-4 (Class A/B) or Form MD-8 (Class C/D) for a licence in Form MD-6 or MD-10.

Applicable Standards for Nebulizers

Nebulizers are evaluated against the nebulizing-system standard plus the electro-medical framework:

  • ISO 27427 — anaesthetic and respiratory equipment: nebulizing systems and components (aerosol output and particle size).
  • IEC 60601-1 — general electrical safety for the compressor/electronics.
  • IEC 60601-1-2 — electromagnetic compatibility (EMC).
  • IEC 60601-1-11 — where intended for the home-healthcare environment.
  • ISO 10993 series — biocompatibility of the mask, mouthpiece and medication cup.
  • Aerosol particle-size distribution (MMAD) evidence as required by the standard.

Documents Required for CDSCO Registration of Nebulizers

Whether you file for a manufacturing or an import licence, CDSCO expects the same core technical dossier built around the device:

  • Covering letter and application form — Form MD-3 (manufacture) or Form MD-14 (import) on the CDSCO Medical Device Online (SUGAM) portal, stating every device, variant and site.
  • Device Master File (DMF) — device description and intended use, materials, design and manufacturing information, ISO 14971 risk file, verification/validation data, sterilisation validation where applicable, shelf-life/stability data and the Essential Principles checklist.
  • Plant Master File (PMF) — site layout, equipment, utilities/HVAC, organisation chart with competent technical staff and the QMS procedures governing production.
  • ISO 13485 QMS certificate — current, with a scope covering the device.
  • Essential Principles of Safety and Performance — a completed checklist mapping the device against each applicable principle with the standard/evidence relied on.
  • Risk management file (ISO 14971) — hazards, risk controls and residual-risk justification.
  • Test / performance reports — against the applicable BIS/IS or ISO/IEC standards from an accredited laboratory.
  • Labels, IFU and packaging — meeting the labelling requirements of the Medical Devices Rules (manufacturer, licence number, sterile status, single-use symbols).
  • Undertaking and declaration of conformity to the Essential Principles and applicable standards.
  • Government fee receipt — paid online through the CDSCO portal.

Device-Specific Documents for Nebulizers

Device-specific documents on top of the core set for nebulizers:

  • ISO 27427 performance report — aerosol output rate and particle-size distribution (MMAD/respirable fraction).
  • IEC 60601-1 / -1-2 reports for electrical safety and EMC.
  • Biocompatibility for the mask, mouthpiece and medication chamber.
  • Cleaning/disinfection validation for reusable patient parts.
  • Noise-level and duty-cycle data where claimed.
  • Country-of-origin approval and Free Sale Certificate for imports.

For an import licence (Form MD-14) there are three further essentials:

  • Free Sale Certificate (FSC) — from the National Regulatory Authority of the country of origin, legalised (apostille/embassy attestation).
  • Country-of-origin regulatory approval — US FDA 510(k)/PMA, EU CE certificate or equivalent.
  • Power of Attorney and Authorised Agent licence — notarised, legalised PoA to the Indian Authorised Agent, plus the agent’s valid wholesale/manufacturing licence.

QMS & Essential Principles — What CDSCO Checks

  • Essential Principles of Safety and Performance (Fifth Schedule) — the device must be safe and perform as intended, with risks reduced as far as possible. Shown through recognised standards and the risk-management file.
  • Quality Management System (ISO 13485) — design controls, supplier control, process validation, traceability, complaint handling and CAPA, evidenced at audit.
  • Risk management (ISO 14971) — a living file with residual risks justified and communicated in the IFU.
  • Clinical evidence — proportionate to the class: clinical evaluation for lower-risk devices and clinical investigation data for many Class C/D and novel devices.

Label & IFU Requirements Specific to Nebulizers

Nebulizer labelling and the IFU are checked for output and use information:

  • Device name, model and nebulizer type (jet/ultrasonic/mesh).
  • Manufacturer name and address, and the CDSCO licence number.
  • Rated electrical supply and the IEC 60601 safety symbols.
  • Batch/serial identification and the date of manufacture.
  • Cleaning/disinfection and part-replacement information in the IFU.

Device vs Drug-Device: When the Medication Comes With It

A nebulizer sold empty is a Class B device. But if it is presented pre-filled or co-packaged with a specific medication, or marketed for a specific drug, it becomes a drug-device combination and the medication is regulated in its own right. Keep the device registration and any drug clearly separated, and confirm at the outset whether you are registering the hardware alone or a combination — it changes the dossier and the reviewers.

Step-by-Step CDSCO Registration Process for Nebulizers

  1. Confirm the classification. Fix the risk class against the CDSCO classification list and the First Schedule — Class B here — which decides the form, authority, fee and audit route.
  2. Choose the route. Manufacture (Form MD-3 → MD-5) or import (Form MD-14 → MD-15). Importers appoint an Indian Authorised Agent holding a valid manufacturing or wholesale licence.
  3. Build the Device Master File and Plant Master File. Assemble device description, materials, design and process data, the ISO 14971 risk file, sterilisation/stability data and the site file with the QMS.
  4. Complete the Essential Principles checklist. Map the device against each applicable essential principle and cite the BIS/IS or ISO/IEC standard or test report relied on.
  5. Draw the test and performance reports. Test to the applicable standards at an accredited laboratory. Sterile and measuring devices carry additional validation.
  6. Register and file on the CDSCO Online (SUGAM) portal. Create the account, pay the government fee online and upload the full dossier under the correct form.
  7. Site audit / inspection. A CDSCO-empanelled Notified Body audits the site. For Class A the audit is post-grant. For Class B the Notified Body conducts it before the licensing authority grants the licence.
  8. Respond to queries and receive the licence. Answer the deficiency letter within the stipulated period. On approval the licence issues in Form MD-5 (manufacture) or MD-15 (import).

CDSCO Registration Fees and Timeline for Nebulizers

The Second Schedule of the Medical Devices Rules sets the fees, and you pay them online through the CDSCO portal. For manufacture of a Class B device the fee is Rs 5,000 per site plus Rs 500 for each distinct device, paid to the State Licensing Authority (SLA). CDSCO charges import fees under Form MD-15 per site and per device in USD — roughly USD 1,000 per site plus USD 50 per device for lower-risk devices, up to about USD 3,000 per site plus USD 1,500 per device for Class C and D. A test licence (Form MD-13) carries a modest fee. Always confirm the current figure on the CDSCO portal before filing.

A complete Class B manufacturing file typically clears in about three to six months. An import (MD-15) file usually takes six to nine months. Every deficiency letter effectively restarts the clock. Unlike the old registration certificates, an MDR 2017 licence does not expire — it stays valid as long as you pay the retention fee (equal to the licence fee) every five years and meet the conditions of licence.

Common Mistakes That Trigger a CDSCO Query

Common query reasons for nebulizer applications are:

  • Particle-size / aerosol-output performance not evidenced to ISO 27427.
  • IEC 60601-1 / -1-2 reports missing or not for the exact model.
  • No cleaning/disinfection validation for reusable patient parts.
  • A medication co-pack filed as a plain device with no drug data.
  • Free Sale Certificate scope not covering the model on import.

Related Approvals to Plan Alongside CDSCO

  • DGFT Importer-Exporter Code — mandatory for any importer of record before the first consignment.
  • Wholesale / sale licence (Form 20B/21B or Form MD-42) — for stocking and distributing the device. The Indian Authorised Agent for an import licence must already hold one.
  • Legal Metrology (LMPC) registration — importers of pre-packaged devices declare MRP, net quantity, importer details and country of origin on the pack.
  • BIS certification — where the device or its electrical components fall under a mandatory BIS/CRS scheme.

Post-Approval Obligations

  • Print the licence number on the label and keep the Essential Principles conformity current.
  • Operate a Post-Market Surveillance (PMS) system and file the Periodic Safety Update Report (PSUR) on the schedule for the device’s class.
  • Report adverse events and field safety corrective actions through the Materiovigilance Programme of India (MvPI) and to CDSCO within the prescribed timelines.
  • Report any change in device, materials, site, labelling or QMS, and any regulatory action or recall in another country.
  • Retain distribution records for traceability and allow CDSCO to draw samples and inspect the premises.
  • Pay the retention fee every five years to keep the licence in force, and track BIS/ISO standard revisions.

FAQs on CDSCO Registration for Nebulizers

What CDSCO class is a nebulizer?

A nebulizer is Class B. A domestic manufacturer files Form MD-3 for an MD-5 licence from the State Licensing Authority. An importer files Form MD-14 for an MD-15 licence.

Which standard applies to nebulizers in India?

ISO 27427 for nebulizing systems (aerosol output and particle size), with IEC 60601-1 electrical safety and IEC 60601-1-2 EMC for the electronics.

Does CDSCO require a factory audit?

Yes — for Class B manufacture a CDSCO-empanelled Notified Body audits the site before the licensing authority grants the MD-5 licence.

What if the nebulizer is sold with medication?

Then it is a drug-device combination and the medication is regulated separately. The device and drug elements must be handled distinctly in the application.

How long does registration take?

A complete Class B manufacturing (MD-5) file usually clears in about three to six months. An import (MD-15) file typically takes six to nine months.

Does the licence expire?

No — the MDR 2017 licence is perpetual, subject to the five-yearly retention fee and continued compliance.

Related CDSCO Registration Guides

Need end-to-end help? See our CDSCO registration services, or read these related guides:

Official references: Central Drugs Standard Control Organisation (CDSCO) and the CDSCO MD Online portal.

Why Choose PCN India Global

  • Classification triage — we confirm the correct risk class for your nebulizers against the current CDSCO list before we draft anything.
  • Route selection — manufacture (MD-3/MD-5) or import (MD-14/MD-15), with the Indian Authorised Agent arrangement handled.
  • Dossier build — Device Master File, Plant Master File, Essential Principles checklist and ISO 13485/ISO 14971 readiness.
  • Standards and testing — the right BIS/IS or ISO/IEC standards mapped and accredited test reports coordinated.
  • End-to-end SUGAM filing — application, audit support, query response and the licence grant managed for you.
  • Adjacent approvals — DGFT/IEC, LMPC, wholesale/sale licence and BIS coordinated alongside your CDSCO licence.

PCN India Global manages the complete CDSCO process for nebulizers — from classification and route selection to Device and Plant Master File preparation, SUGAM filing, audit support and the licence grant. WhatsApp or call +91 9289587478, or email admin@pcnindiaglobal.com, to get your registration underway.

Related Compliance Guides